We use necessary cookies to make our website work. We also use optional statistical, functional and marketing cookies that you can choose to decline in your preference setting. For more information about the use of cookies or our use of data, see our Cookies notice or Privacy notice

Cookies settings I agree I refuse

Cookies information

Our site uses tools, such as cookies, to analyze and improve your experience. You can unsubscribe below:

Statistics

We use tools, such as Google Analytics, to track web traffic and verify the effectiveness of our site.

Necessary

Cookies required for essential services and features such as login forms, shopping cart integration and access control. Without them, our website cannot function properly and we cannot provide any services. Deactivation is not available.

These settings will be kept for 24h

Investors

Bioxodes is a Belgian private company, founded in 2010. The Company has received fundings from both public and private investors.

Why Invest

Investors

Public & private investors

Private Equity
(Euros)

13.6 million
13.6 million

Grants/subsidies from the Walloon Region
(Euros)

8.5 million
8.5 million

Investors

Who invests?

Investors

Why invest?

Invest in us

  • First-in-class lead compound with solid preclinical and Phase I clinical data.

  • Discovery program for innovative pipeline to extend value capture beyond thrombo-inflammation.

  • Leadership and expertise with international advisor network.

  • Patent portfolio wholly owned with coverage beyond 2040.

Investors

Invest in us

Get in touch and explore our investment opportunities

investment@bioxodes.com